IHH Healthcare
This article may have been created or edited in return for undisclosed payments, a violation of Wikipedia's terms of use. It may require cleanup to comply with Wikipedia's content policies, particularly neutral point of view. (September 2021) |
Company type | Public company |
---|---|
MYX: 5225 SGX: Q0F | |
ISIN | MYL5225OO007 |
Industry | Healthcare |
Predecessor | Integrated Healthcare Holdings Bhd |
Founded | 1974 |
Headquarters | , Malaysia |
Areas served | Malaysia, Singapore, Turkey, India, Greater China and across Asia and Europe |
Key people | Tan Sri Dr Nik Norzrul Thani (Chairman and independent non-executive director) Dr Prem Kumar Nair (Group chief executive officer) |
Brands | Acibadem, Mount Elizabeth, Gleneagles Pantai, Parkway, Fortis, Prince Court |
Revenue | RM 6.1 billion |
Number of employees | 70,000 |
Subsidiaries | Parkway Pantai, Acıbadem Healthcare Group |
Website | ihhhealthcare |
IHH Healthcare Berhad (MYX: 5225) is an international private healthcare group focused on upmarket health services, and is Asia's largest private healthcare group. It is headquartered in Kuala Lumpur and has a wide geographical footprint throughout Malaysia, Singapore, Turkey, India, Greater China (including Hong Kong) and across Asia and, Central and Eastern Europe. The group has over 70,000 employees across 80 hospitals in 10 countries. It is listed on Bursa Malaysia and the Singapore Exchange.[1]
The largest shareholder of IHH Healthcare is Mitsui of Japan followed by the Malaysian government's sovereign wealth fund Khazanah Nasional and Citigroup of the United States. A further stake is held by the Employees Provident Fund of Malaysia.
The chairman of IHH is Tan Sri Dr Nik Norzrul Thani bin N Hassan Thani. [2]
See also
[edit]References
[edit]- ^ High Market Cap Propels Hospital Operator IHH Into Top 50, in Forbes Asia, 8 September 2014
- ^ "Meet our new Chairman". 23 July 2024.